Status:
COMPLETED
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
Lead Sponsor:
Viatris Innovation GmbH
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The goal of this study is to find out how fast a drug called selatogrel (ACT-246475) can prevent platelets from binding together. This study will also help to find out more about the safety of this ne...
Detailed Description
This study is planned in patients presenting with Acute Myocardial Infarction (AMI) scheduled for an invasive strategy. Platelet activation and thrombus formation play a pivotal role in the pathophysi...
Eligibility Criteria
Inclusion
- Main
- Informed consent obtained prior to any study-mandated procedure,
- Males aged from 18 to 85 and postmenopausal females aged up to 85 years,
- Onset of symptoms of AMI of more than 30 min and less than 6 hours prior to randomization,
- Subjects presenting a type I AMI including STEMI or NSTEMI.
- Main
Exclusion
- Cardiogenic shock or severe hemodynamic instability,
- Cardiopulmonary resuscitation,
- Loading dose of any oral P2Y12 receptor antagonist prior to randomization,
- Planned fibrinolytic therapy or any fibrinolytic therapy administered within 24 h prior to randomization,
- Known platelet disorders (e.g., thromboasthenia, thrombocytopenia, von Willebrand disease).
- Active internal bleeding, or bleeding diathesis or conditions associated with high risk of bleeding.
- Known clinically important anemia.
- Oral anticoagulation therapy within 7 days prior to randomization
Key Trial Info
Start Date :
July 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03487445
Start Date
July 10 2018
End Date
November 10 2018
Last Update
July 9 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
OLV Ziekenhuis Aalst
Aalst, Belgium, 9300
2
UZLeuven
Leuven, Belgium, 3000
3
Galilee Medical Center
Nahariya, Israel, 22100
4
Universitätsspital Basel
Basel, Switzerland, 4031